Clinical Trial Update: Mini-CHOP and Rituximab in Patients Aged Over 80 Years [Phase 2]

View source ↗

Summary

Phase 2 trial update on Mini-CHOP plus Rituximab in patients over 80 with diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Mini-CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone)
• Rituximab (rituximab)

Snippet

Sponsor: Lymphoma Study Association | Conditions: Diffuse Large B-Cell Lymphoma | Phase 2 | Status: COMPLETED